Aptose Biosciences Inc.
APTOF
$1.60
-$0.06-3.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.11% | 47.58% | 54.78% | 50.34% | 27.31% |
| Total Depreciation and Amortization | -1.92% | -8.80% | -11.26% | -13.30% | -8.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.73% | -95.86% | -93.76% | -85.76% | -59.33% |
| Change in Net Operating Assets | -66.52% | -2,080.30% | -479.74% | -587.60% | -544.53% |
| Cash from Operations | 34.88% | 27.22% | 40.06% | 19.33% | 15.49% |
| Capital Expenditure | -- | -- | 82.76% | 82.76% | 100.00% |
| Sale of Property, Plant, and Equipment | -72.22% | -72.22% | 2,100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -81.84% | -100.00% | -92.44% |
| Cash from Investing | -100.00% | -100.00% | -81.64% | -99.82% | -92.36% |
| Total Debt Issued | 103.50% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.30% | -96.28% | -69.17% | 142.92% | 188.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 193.41% | 190.70% | -- | -- | -1,570.00% |
| Cash from Financing | -34.88% | -9.91% | 19.72% | 383.56% | 349.70% |
| Foreign Exchange rate Adjustments | 100.00% | -- | 150.00% | -100.00% | -112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.47% | -9,945.71% | 83.11% | 90.82% | 36.78% |